ODIXa-DVT FactorXa inhibitor BAY 59-7939 in patients with acute symptomatic deep vein thrombosis - a phase II dose finding and proof or principle trial - Protocol E53/0304

  • Leyden, Michael (Primary Chief Investigator (PCI))
  • Salem, Hatem (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/0430/06/05